Safety of the PET-511BTM Transesophageal Transducer

NCT00997568 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2010-08-20

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the safety of the redesigned transesophageal echocardiogram (TEE) transducer as it is inserted and transitioned into the esophagus through the mouth.

Conditions

  • Patient Requiring TEE Procedure by Their Physician

Interventions

DEVICE

PET-511BTM

Transesophageal Transducer

Sponsors & Collaborators

  • Toshiba America Medical Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • Gregory B. Clarke, M.D · The Christ Hospital

  • David Rubensen, M.D. · Scripps Health

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00997568 on ClinicalTrials.gov